Warm vs Cold Autoimmune Hemolytic Anemia on COMLEX

Warm autoimmune hemolytic anemia is caused by IgG antibodies that bind red cells at body temperature, and the spleen eats the coated cells, which leaves spherocytes on the smear. Cold autoimmune hemolytic anemia is caused by IgM antibodies that bind red cells in the cool fingers, ears, and nose, fix complement, and clump the cells together. The direct antiglobulin test (DAT) separates them: warm is positive for IgG, with or without C3, and cold is positive for C3 alone.

Why do board questions pair warm and cold autoimmune hemolytic anemia?

Both are autoimmune hemolytic anemias (AIHA), so both share the same core labs. The patient is anemic, the reticulocyte count is high, LDH and indirect bilirubin are up, and haptoglobin is low. A stem that only gives you those findings has told you "hemolysis" and nothing more.

The question writers then hand you one or two details that decide which antibody is at work. Temperature, the trigger, the smear, and the DAT result each point one way. Once you know what IgG and IgM do differently, every one of those clues follows from the antibody.

Here's the core idea. IgG is a small, single-unit antibody that binds best at 37°C and doesn't activate complement well. IgM is a large pentamer that binds best in the cold and activates complement very well. Almost every difference between warm and cold AIHA comes from that one contrast.

What does the direct antiglobulin test show in each?

The DAT, also called the direct Coombs test, asks whether anything is already stuck to the patient's red cells. The lab washes the patient's red cells and adds anti-human globulin reagents. If antibody or complement is coating the cells, the reagent bridges them and they agglutinate.

Labs run the DAT with separate reagents for IgG and for C3 (usually C3d, the fragment that stays on the cell). That split is what the board question is testing.

Why is cold AIHA negative for the antibody itself? IgM binds red cells in the cold periphery, fixes complement, and then lets go when the blood returns to the warm core. The C3 stays behind on the cell surface. By the time the sample reaches the lab at body or room temperature, the IgM is gone and only the complement shows up.

Don't confuse the direct and indirect tests. The indirect Coombs test looks for free antibody in the patient's serum, and it's the test behind pre-transfusion antibody screens and prenatal Rh screening. When a stem asks which test confirms autoimmune hemolysis, the answer is the direct test.

Warm autoimmune hemolytic anemia: IgG and the spleen

Mechanism of warm AIHA

Warm AIHA is the more common form in adults. The IgG antibody is usually directed at Rh-family proteins on the red cell surface. It binds at body temperature, so the hemolysis isn't tied to cold exposure.

Splenic macrophages carry Fc receptors that grab the IgG on the coated red cells. Sometimes the macrophage eats the whole cell. Other times it bites off a piece of membrane and releases the rest of the cell back into circulation. A red cell that loses membrane but keeps its volume rounds up into a spherocyte.

This is extravascular hemolysis. The destruction happens inside macrophages, mostly in the spleen, so hemoglobinuria isn't the classic finding. Splenomegaly is common because the spleen is working overtime.

Smear and lab findings in warm AIHA

Spherocytes are the smear finding to know. They're small, dense, round cells without central pallor, and they raise the MCHC. Polychromasia reflects the reticulocyte response. LDH and indirect bilirubin are elevated and haptoglobin is low, as in any hemolysis.

Jaundice and pigment gallstones can follow from the chronic rise in bilirubin. A patient who also has immune thrombocytopenia has Evans syndrome, and the ITP vs TTP vs HUS vs DIC guide covers how to sort the platelet side of that picture.

Causes of warm AIHA

About half of warm AIHA cases are idiopathic. The rest are secondary, and the stem usually names the cause in the history.

• Systemic lupus erythematosus. The classic autoimmune setting, often in a young woman with joint pain, rash, or kidney findings.
• Chronic lymphocytic leukemia. The classic malignancy behind warm AIHA. Expect an older adult with lymphocytosis and smudge cells.
• Other lymphomas. Non-Hodgkin lymphomas can drive it, and the Hodgkin vs non-Hodgkin lymphoma guide covers the rest of that differential.
• Drugs. Methyldopa is the classic example of a drug that induces a true IgG autoantibody. Penicillin and cephalosporins cause drug-dependent immune hemolysis through a different route, where the drug sits on the red cell membrane and the antibody targets the drug.
• Immunodeficiency. Common variable immunodeficiency is a known association.

Treating warm AIHA

Glucocorticoids are the first-line board answer, usually prednisone. Rituximab, an anti-CD20 monoclonal antibody, is the next step when steroids fail or the patient relapses. Splenectomy removes the main site of destruction and remains an option for refractory disease.

Transfusion is given for severe or symptomatic anemia, even though crossmatching is harder because the antibody reacts with nearly every donor cell. Folic acid supplementation supports the high red cell turnover. If a drug is the cause, stop it.

Cold autoimmune hemolytic anemia: IgM and complement

Mechanism of cold agglutinin disease

Cold AIHA is mostly cold agglutinin disease. The IgM antibody is usually directed at the I antigen on adult red cells. It binds in the cooler blood of the fingers, toes, ears, and nose, where the temperature drops below core body temperature.

IgM is a pentamer with ten binding sites, so one molecule can grab several red cells at once. That's why the cells clump together (agglutinate). IgM also fixes complement strongly, and that leads to two kinds of destruction.

Most cells come back to the warm core coated with C3b. Kupffer cells in the liver recognize C3b and clear those cells, which is extravascular hemolysis in the liver rather than the spleen. When complement activation runs all the way to the membrane attack complex, the cells lyse inside the vessels, which is intravascular hemolysis. That intravascular piece is why hemoglobinuria shows up in cold disease.

Clinical and smear findings in cold AIHA

The physical exam gives it away. Acrocyanosis means blue or purple, sometimes painful fingers, toes, ears, and nose after cold exposure. Symptoms worsen in winter and improve with warmth. Dark urine after cold exposure reflects hemoglobinuria.

The smear shows red cell agglutination, clumps of red cells stuck together. Spherocytes are less prominent than in warm AIHA.

Automated cell counters create a classic lab artifact. A clump of agglutinated cells passes through the counter as one large particle. That makes the MCV falsely high, the red cell count falsely low, and the MCHC falsely high. Warming the sample to 37°C breaks up the clumps and corrects the numbers. If a stem gives you a strangely high MCV that normalizes on a warmed sample, think cold agglutinins.

Causes of cold AIHA

• Mycoplasma pneumoniae. The classic infectious trigger. Expect a young adult with "walking pneumonia," a dry cough, and patchy infiltrates, and sometimes bullous myringitis. The anti-I antibody appears a week or two into the illness, and the hemolysis is usually transient.
• Epstein-Barr virus. Infectious mononucleosis can produce a cold agglutinin, classically directed at the i antigen rather than I. The stem gives you fever, pharyngitis, lymphadenopathy, and atypical lymphocytes.
• Lymphoproliferative disorders. Chronic primary cold agglutinin disease is driven by a clonal B-cell population that makes a monoclonal IgM. Waldenström macroglobulinemia and other B-cell lymphomas are the associations to know in an older adult.

Treating cold AIHA

Avoiding cold is the foundation. Keep the patient warm, and run transfusions and IV fluids through a blood warmer. For infection-triggered disease, treat the infection and expect the hemolysis to settle.

Glucocorticoids don't work well in cold agglutinin disease, and that makes them a classic wrong answer. Splenectomy doesn't help either, because the liver, not the spleen, clears the C3b-coated cells. Rituximab is used for chronic primary disease because it targets the B-cell clone. Sutimlimab, an antibody against complement C1s, was approved by the FDA in 2022 for hemolysis in cold agglutinin disease. Boards are more likely to test why steroids and splenectomy fail than to test the newest drug.

Warm vs cold autoimmune hemolytic anemia side by side

Use this table for elimination. Find one feature that doesn't fit, and the other diagnosis is gone.

How is paroxysmal cold hemoglobinuria different?

Paroxysmal cold hemoglobinuria (PCH) is the third immune hemolytic anemia that shows up as a distractor. It's caused by the Donath-Landsteiner antibody, an IgG directed at the P antigen. The antibody is called biphasic because it binds red cells and fixes complement in the cold, then the complement lyses the cells once the blood warms.

PCH is classically seen in children after a viral infection, and historically in tertiary syphilis. The hemolysis is intravascular and sudden, so the stem gives you dark red or brown urine after cold exposure. The DAT is usually positive for C3 alone, just like cold agglutinin disease, so the age and the acute post-viral story separate them.

Don't mix PCH up with paroxysmal nocturnal hemoglobinuria (PNH). PNH isn't autoimmune at all. It's an acquired PIGA mutation that leaves red cells without CD55 and CD59, so complement lyses them. The DAT is negative, and flow cytometry makes the diagnosis.

Which other hemolytic anemias show up as distractors?

A hemolysis question usually offers several answer choices that share the same core labs. The DAT and the smear eliminate most of them in one pass.

The highest-yield confusion is warm AIHA versus hereditary spherocytosis. Both show spherocytes, a high MCHC, and splenomegaly. A positive DAT means the spherocytes are immune-mediated. A negative DAT with a family history points to an inherited membrane defect in spectrin, ankyrin, or band 3. The iron deficiency vs anemia of chronic disease guide covers the low-reticulocyte side of the anemia workup.

Three hemolysis stems: working the split

Here are three example stems built to show the split. Each patient has anemia, a high reticulocyte count, a high LDH, and a low haptoglobin.

Patient 1. A 68-year-old man has fatigue and a palpable spleen tip. His white count is 46,000/µL with mature-appearing lymphocytes and smudge cells. Hemoglobin is 8.7 g/dL, and the smear shows many spherocytes. The DAT is positive for IgG.

The smudge cells and lymphocytosis point to chronic lymphocytic leukemia, and the IgG-positive DAT with spherocytes makes this warm AIHA. The first-line treatment for the hemolysis is a glucocorticoid. Splenectomy is reserved for refractory disease.

Patient 2. A 22-year-old college student has two weeks of low-grade fever, headache, and a dry cough. A chest radiograph shows patchy bilateral infiltrates. She now notices that her fingers turn blue when she walks to class in the cold. The automated MCV is 118 fL and falls to 92 fL after the sample is warmed. The DAT is positive for C3 and negative for IgG.

The atypical pneumonia in a young adult points to Mycoplasma pneumoniae. The acrocyanosis, the falsely high MCV that corrects with warming, and the C3-only DAT all point to cold agglutinins. Steroids are the trap answer here. Keeping her warm and treating the infection is the right approach.

Patient 3. A 6-year-old boy had an upper respiratory infection 10 days ago. After playing outside in the snow, he has sudden pallor, abdominal pain, and dark brown urine. The DAT is positive for C3 only.

A child, a recent viral illness, cold exposure, and abrupt intravascular hemolysis point to paroxysmal cold hemoglobinuria. The Donath-Landsteiner antibody is the cause, even though the DAT pattern matches cold agglutinin disease.

If you want more worked stems like these, the free Skool community has a video library of question breakdowns.

Stem clues that crack these questions fast

The clues I look for in every question are age, acuity, unusual findings, matching timelines, laterality, labs and imaging, and the question part. Here's how they apply to immune hemolysis.

1. Age. A young adult with atypical pneumonia points to Mycoplasma and cold agglutinins. An older adult with lymphocytosis points to CLL and warm AIHA. A child after a viral illness with sudden dark urine points to PCH.
2. Acuity. Abrupt hemoglobinuria after cold exposure means intravascular hemolysis. Slow fatigue with jaundice and splenomegaly fits extravascular warm disease.
3. Unusual findings. Blue fingertips and ears after cold exposure belong to cold AIHA. A stem rarely mentions cold weather for no reason.
4. Matching timelines. Hemolysis that starts one to two weeks into a respiratory infection fits Mycoplasma. Hemolysis that starts after a new drug fits drug-induced disease.
5. Labs are king. Read the DAT first. IgG positive is warm. C3 alone is cold. A negative DAT means look outside autoimmune hemolysis.
6. The question part. "Most likely antibody," "site of destruction," and "most appropriate treatment" each ask something different. Read the last sentence before you commit.

When two answers both look right on a hemolysis question, the guide to choosing between two answers on COMLEX walks through how to break the tie.

Common board pitfalls and how to avoid them

Pitfall 1 is giving steroids for cold agglutinin disease. Steroids are first line for warm AIHA and work poorly in cold disease. Warmth, treating the cause, and rituximab are the cold answers.

Pitfall 2 is choosing splenectomy for cold AIHA. The liver clears C3b-coated cells in cold disease, so removing the spleen doesn't help. Splenectomy belongs to refractory warm AIHA.

Pitfall 3 is reading a C3-only DAT as negative for autoimmunity. A C3-only DAT is the expected cold pattern, because the IgM has already let go of the cell.

Pitfall 4 is calling every spherocyte hereditary spherocytosis. Check the DAT. Positive means warm AIHA, and negative with a family history means hereditary spherocytosis.

Pitfall 5 is trusting a high MCV in a cold stem. Agglutinated clumps fool the counter. A macrocytosis that disappears after warming is an artifact, not a B12 or folate problem.

Pitfall 6 is confusing PCH with PNH. PCH is an autoimmune IgG cold antibody with a positive DAT. PNH is a PIGA mutation with a negative DAT and loss of CD55 and CD59.

Frequently asked questions about warm vs cold autoimmune hemolytic anemia

What is the main difference between warm and cold autoimmune hemolytic anemia?

The antibody class. Warm AIHA is caused by IgG that binds red cells at body temperature, and splenic macrophages remove the coated cells, which leaves spherocytes on the smear. Cold AIHA is caused by IgM that binds red cells in the cool periphery, clumps them together, and fixes complement. The liver clears the complement-coated cells, and some cells lyse inside the vessels. The DAT shows IgG in warm disease and C3 alone in cold disease.

Why is the DAT positive only for C3 in cold agglutinin disease?

IgM binds red cells in the cold fingers, ears, and nose and fixes complement there. When the blood returns to the warm core, the IgM lets go of the cell, but the C3 fragments stay attached. By the time the sample is tested, only complement remains on the cell surface. That's why the anti-IgG reagent comes back negative and the anti-C3 reagent comes back positive. Paroxysmal cold hemoglobinuria shows the same C3-only pattern.

What infections cause cold autoimmune hemolytic anemia?

Mycoplasma pneumoniae and Epstein-Barr virus are the two classic infectious triggers. Mycoplasma produces an anti-I cold agglutinin about one to two weeks into an atypical pneumonia, usually in a young adult. Infectious mononucleosis from EBV produces an anti-i cold agglutinin. In both cases, the hemolysis is usually mild and transient, and it resolves as the infection clears. Chronic cold agglutinin disease in older adults instead points to a B-cell lymphoproliferative disorder such as Waldenström macroglobulinemia.

Why don't steroids work for cold agglutinin disease?

Glucocorticoids work in warm AIHA largely by lowering autoantibody production and by blunting splenic macrophage clearance of IgG-coated cells. Cold agglutinin disease runs on IgM and complement, with clearance in the liver, so steroids have little effect on the main mechanism. That makes steroids a common wrong answer on cold stems. The correct approach is cold avoidance, treating any underlying infection, rituximab for chronic disease, and newer complement-blocking drugs such as sutimlimab.

How do you tell warm AIHA from hereditary spherocytosis?

Both show spherocytes, a high MCHC, splenomegaly, and signs of hemolysis. The DAT decides. Warm AIHA has a positive DAT for IgG, because an autoantibody is coating the cells. Hereditary spherocytosis has a negative DAT, because the spherocytes come from an inherited membrane protein defect in spectrin, ankyrin, or band 3. A family history, onset in childhood, and a positive EMA binding test also point to hereditary spherocytosis.

What causes the falsely high MCV in cold agglutinin disease?

Agglutinated red cells clump together at room temperature in the collection tube. The automated counter reads each clump as a single large cell, so the MCV is falsely high and the red cell count is falsely low. The MCHC also comes out falsely high. Warming the sample to 37°C breaks up the clumps and brings the indices back to their true values. A stem that shows this correction is pointing you to cold agglutinins.

Related guides

• ITP vs TTP vs HUS vs DIC
• Iron deficiency anemia vs anemia of chronic disease on board exams
• Hodgkin vs non-Hodgkin lymphoma on COMLEX
• How do I choose between two answers on COMLEX?
• Doctor Lucas DO on YouTube: hematology question breakdowns and high-yield clinical comparison videos